Biocon ranked 13 among top 20 biotech employers by ‘Science’ magazine
- Businesses should adjust to one-day loan default norm: SBI chief Rajnish Kumar
- Cyient Q4 profit up 16.2% to Rs121.5 crore
- TCS Q4 profit rises 4.5% to Rs6,904 crore, beats market expectations
- Supreme Court grants Sahara time till 15 May to sell its property inside Aamby Valley
- Jio propels Mukesh Ambani to World’s Greatest Leaders list
Hyderabad: Drug maker Biocon Ltd on Tuesday said it was ranked 13 among the world’s top 20 biotech employers for 2015 by the US-based magazine Science.
The ranking is the outcome of a global survey conducted by the American Association for the Advancement of Science (AAAS) through its affiliate Science magazine to find out the top 20 global employers in the pharma sector.
The top companies were shortlisted from the list of more than 181 global companies after a web-based survey of more than 5,700 respondents on 23 different attributes.
Biocon has been recognized for three key attributes—innovative leader in the industry, loyal employees and socially responsibility, the company said.
The list was topped by world’s largest industrial enzyme maker Denmark-based Novozymes AS followed by US-based drug discovery company Regeneron Pharmaceuticals, Inc. and another Danish company Novo Nordisk AS.
Biocon is the only company from Asia to appear on the list.
“We are delighted to achieve this global recognition, which is an outcome of our efforts to create an inspiring workplace built on a strong foundation of an innovation-led ecosystem that attracts the best global talent,” said Kiran Mazumdar-Shaw, chairperson and managing director of Biocon.
“At Biocon, we have invested in creating a culture that pursues excellence through learning and adopting global best practices,” Mazumdar-Shaw said.
The 2015 survey allowed respondents to rank the biggest advantages to working in the biopharma industry. Workers voted “innovation” as the top reason, followed by “working with smart colleagues” and “excellent compensation and benefits” as a close number two and three, respectively.